Many studies have demonstrated the overexpression of CD39, CD73, A2aR, and A2bR in both tumor cells and immune cells, which contributes to extracellular adenosine accumulation, intracellular cAMP production and metabolic reprogramming [240–243]. This evidence concerns the gene ADORA2A and neoplasm.